You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Reckitt Benckiser Plc in Consumer Health

Sep 2012

Price: US$525

About this Report

About this Report


Euromonitor International's report on Reckitt Benckiser Plc delivers a detailed strategic analysis of the company's business, examining its performance in the Herbal/Traditional Products market and the global economy.

Company and market share data provide a detailed look at the financial position of Reckitt Benckiser Plc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Reckitt Benckiser Plc This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Reckitt Benckiser Plc provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Herbal/Traditional Products research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

Strategic Evaluation

Key company facts

Strong financial performance continues

Consumer health drives up considerable sales growth

SWOT

Key strategic objectives and challenges

Competitive Positioning

Growth slows down in 2011

Acquisitions and organic performance drive growth for Reckitt

Market Assessment

Strongest in cough, cold and allergy (hay fever) remedies

Reliance on mature markets

Geographic and Category Opportunities

Mature market bias in regional exposure

Leading in the UK’s core treatment OTC products

Poor outlook in the UK drives need to look farther afield

Room for growth in emerging OTC regions

Missing out in high-growth markets

Under-exploited in lucrative Latin America

China a lucrative but tough market in Asia Pacific

Building a material presence in India

Growth prospects for India

Brands grow in isolation

Smaller brands in medicated skin care

Brand Strategy

Concentrating on “ powerbrands ”

Mucinex to grow through geographic expansion

Nurofen : Strong media back up and competition with private label

Strepsils : Wide geographic presence but missing from China

Operations

Operations and R&D

Recommendations

Key takeaways

Data parameters and report definitions

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!